Hormone Optimization Tips and Benefits for Women’s Health

Unlock the secrets of women’s health for hormone optimization, enhancing your vitality and overall well-being.

Abstract

For decades, the conversation surrounding hormone replacement therapy (HRT), particularly for menopausal women, has been clouded by misinformation and fear stemming from the initial interpretations of the Women’s Health Initiative (WHI) study. In this educational post, I will re-examine the WHI study, presenting updated findings from the very same researchers that reveal a completely different, safer, and more beneficial picture of hormone therapy. We will deconstruct the original study’s flaws, focusing on the critical differences between synthetic and bioidentical hormones, and between oral and transdermal delivery systems. I will elaborate on the physiological roles of estrogen, progesterone, and testosterone, explaining why replacing these deficient hormones is crucial for preventing chronic diseases like cardiovascular disease, osteoporosis, and cognitive decline. This post aims to empower both patients and practitioners with a modern, evidence-based understanding of how to safely and effectively use bioidentical hormones to not just alleviate symptoms but to promote long-term health and vitality. We will explore the risks of hormone avoidance versus the minimal, manageable side effects of properly administered therapy, providing a clear, scientifically-backed roadmap for optimal wellness.

As a practitioner with a diverse background in chiropractic, nursing, and functional medicine, holding titles such as DC, APRN, and being a certified functional medicine practitioner (IFMCP), my core mission has always been the transformation of patient health. Through my clinical work at Push-as-Rx, I have seen firsthand how proactive, evidence-based strategies can radically change lives. Today, I want to share insights from leading researchers in the field, particularly the work of my esteemed colleague, Dr. John Payne, a board-certified OB/GYN who has transitioned his practice to focus on proactive wellness. His extensive experience with thousands of patients has provided invaluable clinical data that aligns with the latest research, and I am honored to present these concepts to you.

Rethinking the Women’s Health Initiative: What If They Used the Right Hormones?

The conversation about hormone therapy is often dominated by the shadow of the Women’s Health Initiative (WHI) study from 2002. It was a seismic event in medicine. I remember the deluge of phone calls my office received; the fear was palpable. Overnight, nearly half of all women in the U.S. on hormone therapy stopped their prescriptions. But let’s ask a critical question: What if that landmark study had been designed differently?

What if, instead of using a synthetic progestin (medroxyprogesterone acetate, or Provera) and a conjugated equine estrogen (Premarin), the researchers had used bioidentical hormones? What if they had used a transdermal 17-beta estradiol patch and oral micronized bioidentical progesterone?

The answer is simple: We wouldn’t be having this conversation in the same way. The negative outcomes reported in the WHI—such as an increased risk of blood clots, stroke, and breast cancer—were directly linked to the specific molecules and the delivery systems used.

The Problem with Oral Delivery and Synthetic Molecules

When you take a hormone orally, like the Premarin used in the WHI, it undergoes what we call a “first-pass effect.”

1. The pill is absorbed in your intestines.
2. It travels directly to the liver via the portal circulation.
3. The liver metabolizes a significant portion of it and, in doing so, increases the production of various proteins, including clotting factors and inflammatory markers.

This hepatic first-pass metabolism is the primary reason oral estrogens are associated with an increased risk of venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). It also contributes to the risks of hypertension and gallbladder disease.

However, modern research has shown a completely different safety profile for transdermal estradiol. Study after study has demonstrated that when estrogen is delivered through the skin via a patch, gel, or cream, it bypasses the liver’s first-pass effect. It enters the bloodstream directly, avoiding the surge in clotting factors. In fact, some evidence suggests that transdermal estradiol does not increase—and may even be beneficial for—blood clot risk profiles (Canonico et al., 2007).

The WHI Revisited: A Two-Decade Vindication of Estrogen

The initial media firestorm in 2002 focused on a perceived trend toward increased breast cancer risk in the estrogen-plus-progestin treatment arm of the WHI. This sensationalism created a wave of propaganda that has taken decades to correct.

Let’s look at what the data actually says, as reported by the same researchers in the years that followed.

• 2017 Follow-Up: A follow-up study published in JAMA by the original WHI authors looked at the same group of women after 18 years. Their conclusion was stunning: there was no increase in all-cause mortality, cardiovascular mortality, or cancer-related mortality in the women who had taken the hormones (Manson et al., 2017). In essence, they admitted their initial conclusions were overstated. This update, however, did not make the cover of Time magazine; it was buried in the back pages of a medical journal.
• 2020 Breast Cancer Data: It gets even more compelling. In 2020, further analysis of the WHI data was published, again in JAMA. This time, focusing specifically on the women who took estrogen alone (Premarin, without the synthetic progestin), the results were paradigm-shifting. The researchers were forced to conclude that there was a statistically significant reduction in both the incidence of breast cancer and mortality from breast cancer in this group (Chlebowski et al., 2020).

Let that sink in. The only drug in the history of medicine to ever show a reduction in both the incidence and mortality of breast cancer is an estrogen, and one that we now consider to be a less-than-ideal formulation at that. Imagine the potential benefits of using a safer, bioidentical estradiol. This groundbreaking news was largely ignored, and clinical practice has been slow to change.

The Real Risk: Understanding Hormone Avoidance

In my practice, when a patient and I discuss hormone replacement therapy, the conversation about”risks” is turned on its head. The documented risks associated with the WHI study—blood clots, stroke, breast cancer—are largely negated when we use the right molecule (bioidentical) and the right delivery system (transdermal).

Therefore, the most critical discussion we need to have is about the risks of hormone avoidance. When a woman chooses to “go through menopause naturally,” what does that really mean in the 21st century?

• Cardiovascular Disease: Women’s risk of heart attack and stroke skyrockets after menopause. Estrogen is profoundly protective of the cardiovascular system.
• Osteoporosis and Hip Fractures: Estrogen is essential for maintaining bone density. The decline in estrogen leads directly to osteoporosis, making debilitating hip fractures far more likely.
• Cognitive Decline and Alzheimer’s Disease: Our brains are rich in hormone receptors. The precipitous drop in estrogen is a major contributing factor to the cognitive decline and increased risk of Alzheimer’s disease seen in postmenopausal women.
• Overall Chronic Disease: Nearly every chronic disease of aging increases in incidence and severity in a hormone-deficient state.

Our ancestors rarely lived long past menopause. Today, women can expect to live 30, 40, or even more years after their last menstrual period. The choice is not simply whether to endure hot flashes. The choice is whether to spend the last decades of life active and healthy or to suffer from a cascade of preventable chronic diseases. The risks of hormone avoidance are far more severe and certain than the manageable side effects of properly prescribed bioidentical hormone therapy.

The Symphony of Hormones: Receptors and Their Purpose

The ancient Greeks used the word hormone to mean “to set in motion.” This is a perfect description. Hormones are chemical messengers that travel through the body, bind to specific receptors on cells, and set in motion a cascade of biological actions.

A fundamental principle in endocrinology is this: if a receptor exists in a cell, it’s there for a reason. The body expects that receptor to be stimulated by its corresponding hormone. When the hormone is absent, the function that the cell was meant to perform is compromised. This is the definition of a hormone deficiency state.

Think of your hormones as a cake. The foundational layers are progesterone, estrogen, testosterone, and thyroid. If you don’t get these foundational hormones right—if you don’t bake the cake properly—all the icing, like peptides and nutraceuticals, won’t fix the underlying problem.

• Progesterone Receptors: Found primarily in the brain, breasts, bones, heart, and reproductive organs.
• Estrogen Receptors: Found in the same tissues as progesterone, plus many more throughout the body.
• Androgen (Testosterone) Receptors: Found in nearly 90% of all cells in the body, highlighting their systemic importance.
• Thyroid Receptors: Found in the nucleus of virtually every single cell in the body, making thyroid the master regulator of metabolism.

Our goal with BHRT is to practice endocrine mimicry—to restore the hormonal environment of a healthy young adult, allowing these receptors to function as intended.

Progesterone’s Protective Power: Beyond the Uterus

Progesterone is often misunderstood and incorrectly prescribed. Let’s clarify its role and the critical difference between bioidentical progesterone and its synthetic counterparts, known as progestins.

Bioidentical Progesterone vs. Synthetic Progestins

Pharmaceutical companies developed progestins (such as medroxyprogesterone acetate, used in the WHI) to secure patents. They are molecularly different from the progesterone your body makes. Because of these structural differences, progestins can bind to other hormone receptors (like androgen and corticosteroid receptors), leading to a host of negative side effects:

• Breast pain and tenderness
• Bloating and fluid retention
• Nausea
• Negative mood changes and irritability
• Adverse effects on cholesterol and blood sugar

In contrast, bioidentical micronized progesterone (often prescribed as Prometrium or compounded) is molecularly identical to what your body produces. When it binds to the progesterone receptor, it initiates the intended biological response. Its primary “ide effect” is often sedation, which is why it’s typically taken at bedtime and is wonderful for improving sleep. Over 99% of patients tolerate compounded bioidentical progesterone without the adverse effects associated with progestins.

Progesterone’s Role in the Menstrual Cycle and Menopause

During a normal menstrual cycle, estrogen dominates the first half (the follicular phase), causing the uterine lining (endometrium) to proliferate and thicken. After ovulation, progesterone rises and dominates the second half (the luteal phase). Progesterone’s key role is stabilization. It stops endometrial growth, matures the lining, and prepares it for a potential pregnancy. If no pregnancy occurs, the sharp drop in both hormones triggers menstruation.

Progesterone and estrogen are not adversaries; they are synergistic partners. They are meant to work together.

A common and outdated practice is to only prescribe progesterone to women who still have a uterus, with the sole purpose of protecting the endometrium from the proliferative effects of unopposed estrogen. This is a critical mistake. As we discussed, progesterone receptors are in the brain, breasts, and bones. Women who have had a hysterectomy still have these tissues and derive immense benefit from progesterone, including:

• Improved sleep quality
• Enhanced mood and a sense of calm
• Protection of breast tissue (progesterone is anti-mitotic in normal breast cells)
• Support for bone density

In my practice, every postmenopausal woman is a candidate for progesterone replacement, regardless of her uterine status. We treat the hormone deficiency, not just one organ.

Clinical Pearls for Prescribing Progesterone

• Serum vs. Saliva Testing: I rely on serum (blood) levels for hormone testing. Serum reflects what is systemically available to all tissues, including substances that cross the blood-brain barrier.
• The Ineffectiveness of Creams: Progesterone is a large molecule. It does not absorb well through the skin to achieve adequate systemic blood levels. Patients on progesterone cream consistently show near-zero levels on serum tests. While it may provide local benefits, progesterone cream cannot be relied upon to protect the endometrium in a woman taking estrogen. Systemic progesterone must be given orally (micronized) or sublingually.

By understanding the true physiology and pharmacology of these hormones, we can move past myths and use these powerful tools to build a foundation for lifelong health.

References

• Canonico, M., Oger, E., Plu-Bureau, G., Conard, J., Meyer, G., Lévesque, H., Trillot, N., Barrellier, M. T., Wahl, D., Emmerich, J., Scarabin, P. Y., & ESTHER Study Group. (2007). Hormone therapy and venous thromboembolism among postmenopausal women: Impact of the route of estrogen administration and progestogens: The ESTHER study. Circulation, 115(7), 840–845.
• Chlebowski, R. T., Anderson, G. L., Aragaki, A. K., et al. (2020). Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women’s Health Initiative randomized clinical trials. JAMA, 324(4), 369–380.
• Manson, J. E., Aragaki, A. K., Rossouw, J. E., et al. (2017). Menopausal hormone therapy and long-term all-cause and cause-specific mortality: The Women’s Health Initiative randomized trials. JAMA, 318(10), 927–938.

SEO Tags: hormone replacement therapy, HRT, BHRT, bioidentical hormones, menopause, Dr. Alexander Jimenez, functional medicine, women’s health, estrogen, progesterone, testosterone, Women’s Health Initiative, WHI, transdermal estrogen, hormone deficiency, anti-aging, progesterone benefits, hormone myths, evidence-based medicine